Fidji Simo Exits Full-Time OpenAI Role, Citing Chronic Illness That Has No Cure

What Happened

Fidji Simo posted on X on Thursday, July 9, that she is leaving her full-time role at OpenAI and moving to a part-time advisory position. The reason: a severe and prolonged relapse of Postural Orthostatic Tachycardia Syndrome, or POTS, a neuroimmune condition she was diagnosed with in 2019.

"Three months ago, I had to go on medical leave after a severe exacerbation of a chronic illness I've lived with for seven years," Simo wrote. "During that time, it became clear that the road to recovery would be much longer and more complex than I had anticipated — and that I needed to focus on it fully."

She took a temporary medical leave in April 2026, weeks after being elevated to what OpenAI called the AGI chief or CEO of AGI Deployment role. What was expected to be a brief absence turned into a three-month gap, and now a permanent step back.

The Executive Churn at OpenAI

Simo's departure is the latest in a string of leadership changes at the company that accelerated in April. When she went on leave, COO Brad Lightcap simultaneously stepped away from his COO title to take on "special projects." CMO Kate Rouch also stepped back to focus on cancer recovery, with plans to return in a reduced capacity. Chief Product Officer Kevin Weil has since left the company entirely, according to TechCrunch.

OpenAI President and co-founder Greg Brockman filled the product gap while Simo was out. A memo viewed by The Verge in May formalized Brockman's charge: he now leads four product pillars, including core product and platform, enterprise industries, consumer applications, and infrastructure. The reorganization also officially merged ChatGPT and Codex into a single agentic platform.

Simo joined OpenAI's board in March 2024, then came aboard as CEO of Applications in May 2025. Her hire was explicitly designed to free Sam Altman to focus on research, compute, and safety. With Altman's stated priorities and Simo's responsibilities now both landing back on Altman and Brockman, the bench looks thin for a company carrying an $852 billion valuation, as TechCrunch noted.

What Simo Said

Simo's X post was unusually candid about how she handled illness in her career. She revealed that years earlier at Facebook, CEO Mark Zuckerberg offered her a full year of medical leave. She turned it down without considering it. "He told me I should play the long game. I wish I had listened," she wrote.

She credited her time at OpenAI as clarifying in a painful way: "It has been a jarring experience to spend my days helping build the future while simultaneously navigating a disabling disease that still has no cure."

Sam Altman responded on X: "i am really sad about this and very grateful for all fidji has done for openai, and even grateful for her friendship and who she is as a person. we all wish her the best for a speedy recovery. this sucks."

Implications for OpenAI's Business

Simo's departure poses real challenges for Altman, beyond a simple personnel loss. She was widely seen, according to TechCrunch, as a likely candidate to take on expanded responsibility if and when OpenAI goes public. She had already done it once: she led Instacart through its 2023 IPO, breaking what TechCrunch described as the longest tech IPO drought in three decades.

OpenAI confidentially filed for an IPO last month, a week after rival Anthropic did the same, according to CNBC. But the company has offered no public timeline and is reportedly deferring the debut to at least 2027, with a reported valuation target of $1 trillion per Wired.

Meanwhile, ChatGPT's consumer growth cooled in the second half of 2025, missing internal revenue targets, which pushed OpenAI to lean harder into coding tools, an area where Anthropic currently leads, according to TechCrunch. Simo was the executive responsible for turning that around.

The Case for Continuity

The strongest counterargument to treating this as a crisis: OpenAI has already been operating without Simo for three months and has not visibly fallen apart. Brockman is running product. CFO Sarah Friar and CRO Denise Dresser are handling the business side. The company launched its GPT-5.6 model family and a new agent called ChatGPT Work on the same day Simo's departure was announced, according to TechCrunch. The product pipeline is moving.

The reorganization Brockman oversaw in May also consolidated sprawling teams and eliminated distractions. OpenAI has wound down or scaled back certain far-flung initiatives, according to Wired. The focus strategy could position the company better for an IPO than a wider, harder-to-manage portfolio would.

Still, continuity is doing a lot of work here. The company has lost its CPO, its COO in functional terms, its CMO, and now its top product and business executive within a single calendar year. At an $852 billion valuation, investors and prospective IPO buyers will have questions about who is actually running the day-to-day.

What Comes Next

As of July 10, OpenAI has not announced a successor to Simo's responsibilities. Brockman is holding the product portfolio, but his role was already described in the May memo as running "product strategy and scaling." Whether Altman elevates someone internally, recruits externally, or formally consolidates these duties into Brockman's title is the immediate unresolved question ahead of any IPO filing becoming public.